Search Results for “cancer” – Page 52 – media

Primary care group uses population health IT to help prevent colon cancer

The national average colorectal screening rate is 39 percent but at Albany Area Primary Health Care it's 60 percent.
- Source: Healthcare IT News
- 503
- February 24, 2018
cancer health IT Researches
Merck’s ERK inhibitor shows promise in combo against resistant cancers

One-fifth of patients in a phase 1 study responded to an investigational ERK inhibitor from Merck, bolstering hopes that this type of drug could be used effectively in combination with other cancer drugs. ERK is a cell signal that is believed to drive the growth of many cancers.
- Source: fiercebiotech
- 542
- February 23, 2018
cancer drugs Company Insight inhibitor
Abbott supports Angle’s breast cancer liquid biopsy study

Healthcare firm Abbott will provide its PathVysion HER-2 DNA FISH probe kits for use in Angle's breast cancer liquid biopsy study.
- Source: invitrodiagnostics.medicaldevices-business-review
- 623
- February 13, 2018
Abbott breast cancer liquid biopsy Researches
Genentech’s Tecentriq Impresses Again in Late-Stage Kidney Cancer Trial

Genentech’s PD-L1 inhibitor Tecentriq continues to show off its versatility. Monday, the Roche subsidiary announced a combination of Tecentriq and Avastin (bevacizumab) was significantly beneficial to patients with advanced or metastatic renal cell carcinoma (mRCC) who have not received prior systemic active or experimental therapy.
- Source: Biospace
- 652
- February 11, 2018
Clinical Trial inhibitor mRCC Tecentriq
Scientists discover way to halt breast cancer spread

Scientists have uncovered a key mechanism that facilitates the spread of breast cancer cells, and thus a potential target for new therapeutic approaches in the fight against the disease.
- Source: pharmatimes
- 523
- February 11, 2018
breast cancer L-asparaginase Researches
Paige.AI Created to Transform Cancer Diagnosis and Treatment by Applying Artificial Intelligence to Pathology

Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial intelligence (AI), launches today as it announces two major milestones
- Source: tmcnet
- 547
- February 9, 2018
AI Market Views Series
Pfizer vs J&J– Researchers are duking it out for the championship title in nonmetastatic prostate cancer

Pfizer $PFE and J&J $JNJ have come down to the wire with pivotal data on nonmetastatic prostate cancer. And there are billions of dollars in revenue on the line here.
- Source: Endpts
- 451
- February 7, 2018
Market Views prostate cancer
BMS’ Opdivo and Yervoy combo better than chemo in halting lung cancer progression

Bristol-Myers Squibb has revealed promising data from its ongoing Phase 3 study investigating the efficacy of Opdivo (nivolumab) in combination with Yervoy (ipilimumab) compared to chemotherapy in the first-line treatment of advanced non-small-cell lung cancer (NSCLC) in patients whose cancers have a high tumour mutation burden (TMB), regardless of PD-L1 expression.
- Source: pharmafile
- 552
- February 7, 2018
BMS Chemotherapy NSCLC Opdivo TMB Yervoy
Ultrasound tech genetically controls cells to kill cancer new study finds

Researchers say the approach breaks new ground in treating cancer non-invasively and with unprecedented precision.
- Source: Healthcare IT news
- 577
- February 6, 2018
cancer CAR–T immunotherapy Researches
Prostate cancer now third biggest cancer killer in the UK

The number of men dying from prostate cancer has overtaken the number of women dying from breast cancer for the first time, with the disease now the UK’s third biggest cancer killer.
- Source: pharmatimes
- 510
- February 5, 2018
prostate cancer Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.